Both SARS-CoV-2 infection and COVID-19 vaccines based on the SARS-CoV-2 surface glycoprotein, Spike, generate neutralizing antibodies in SARS-CoV-2 naïve individuals which can prevent infection and/or severe disease. This evidence concerns the gene CHMP5 and infection.